Cargando…

Lipocalin 2 (LCN2) is a promising target for cholangiocarcinoma treatment and bile LCN2 level is a potential cholangiocarcinoma diagnostic marker

Cholangiocarcinoma (CCA) is a devastating disease due to resistance to traditional chemotherapies and radiotherapies. New therapeutic strategies against CCA are urgently needed. This study investigated the role of lipocalin-2 (LCN2) in human cholangiocarcinoma as a potential therapeutic target and d...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chiang, Kun-Chun, Yeh, Ta-Sen, Wu, Ren-Chin, Pang, Jong-Hwei S., Cheng, Chi-Tung, Wang, Shang-Yu, Juang, Horng-Heng, Yeh, Chun-Nan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group 2016
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5080596/ https://www.ncbi.nlm.nih.gov/pubmed/27782193 http://dx.doi.org/10.1038/srep36138

Ejemplares similares

The effect of lipocalin-2 (LCN2) on apoptosis: a proteomics analysis study in an LCN2 deficient mouse model
por: Wu, Dongming, et al.
Publicado: (2021)

Lipocalin 2 (LCN2) Expression in Hepatic Malfunction and Therapy
por: Asimakopoulou, Anastasia, et al.
Publicado: (2016)

Reappraisal of the Therapeutic Role of Celecoxib in Cholangiocarcinoma
por: Yeh, Chun-Nan, et al.
Publicado: (2013)

LCN6, a novel human epididymal lipocalin
por: Hamil, Katherine G, et al.
Publicado: (2003)

MART-10 represses cholangiocarcinoma cell growth and high vitamin D receptor expression indicates better prognosis for cholangiocarcinoma
por: Chiang, Kun-Chun, et al.
Publicado: (2017)

Identification, characterization and expression analysis of rLcn13, an epididymal lipocalin in rats : Characterization of epididymal-specific lipicalin rLcn13
por: Yao, Guangxin, et al.
Publicado: (2023)

Lipocalin (LCN) 2 Mediates Pro-Atherosclerotic Processes and Is Elevated in Patients with Coronary Artery Disease
por: Oberoi, Raghav, et al.
Publicado: (2015)

Depletion of Lipocalin 2 (LCN2) in Mice Leads to Dysbiosis and Persistent Colonization with Segmented Filamentous Bacteria
por: Klüber, Patrick, et al.
Publicado: (2021)

The role of LCN2 and LCN2-MMP9 in spondylitis radiographic development: gender and HLA-B27 status differences
por: Tsui, Florence W. L., et al.
Publicado: (2022)

Expression Analysis of Lipocalin 2 (LCN2) in Reproductive and Non-Reproductive Tissues of Esr1-Deficient Mice
por: Kessel, Jan C., et al.
Publicado: (2023)

The homologous lipocalins Can f 1 and Lcn-1 induce different immune responses
por: Posch, Beate, et al.
Publicado: (2014)

25(OH)D Is Effective to Repress Human Cholangiocarcinoma Cell Growth through the Conversion of 25(OH)D to 1α,25(OH)(2)D(3)
por: Chiang, Kun-Chun, et al.
Publicado: (2016)

The Role of Thyroid Hormone 3,3 ‘, 5 - Triiodothyronine (T3) in the Expression of Osteocalcin and Lipocalin 2 (LCN2) in Osteoblasts
por: de Camargo Andrade, Amanda Fantini, et al.
Publicado: (2021)

Chemopreventive and chemotherapeutic effects of dietary supplementation of vitamin D on cholangiocarcinoma in a Chemical-Induced animal model
por: Chiang, Kun-Chun, et al.
Publicado: (2014)

Interferon α-inducible protein 27 is an oncogene and highly expressed in cholangiocarcinoma patients with poor survival
por: Chiang, Kun-Chun, et al.
Publicado: (2019)

Lipocalin-2 (Lcn-2) Attenuates Polymicrobial Sepsis with LPS Preconditioning (LPS Tolerance) in FcGRIIb Deficient Lupus Mice
por: Ondee, Thunnicha, et al.
Publicado: (2019)

The iron load of lipocalin-2 (LCN-2) defines its pro-tumour function in clear-cell renal cell carcinoma
por: Rehwald, Claudia, et al.
Publicado: (2019)

Chronic diazepam administration increases the expression of Lcn2 in the CNS
por: Furukawa, Tomonori, et al.
Publicado: (2017)

Hepatectomy or/with Metastatectomy for Recurrent Intrahepatic Cholangiocarcinoma: Of Promise for Selected Patients
por: Tsai, Chun-Yi, et al.
Publicado: (2022)

iTRAQ-Based Proteomics Screen identifies LIPOCALIN-2 (LCN-2) as a potential biomarker for colonic lateral-spreading tumors
por: Wang, Xianfei, et al.
Publicado: (2016)

Effect of Sleeve Gastrectomy on Glycometabolism via Forkhead Box O1 (FoxO1)/Lipocalin-2 (LCN2) Pathway
por: Liu, Zhi, et al.
Publicado: (2020)

Lipocalin-2 (LCN2) Deficiency Leads to Cellular Changes in Highly Metastatic Human Prostate Cancer Cell Line PC-3
por: Schröder, Sarah K., et al.
Publicado: (2022)

Stroke Exacerbates Cancer Progression by Upregulating LCN2 in PMN-MDSC
por: Huang, Tingting, et al.
Publicado: (2020)

LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

Resistance to the Bacteriocin Lcn972 Deciphered by Genome Sequencing
por: Escobedo, Susana, et al.
Publicado: (2023)

Molecular Mechanism Underlying Persistent Induction of LCN2 by Lipopolysaccharide in Kidney Fibroblasts
por: Glaros, Trevor, et al.
Publicado: (2012)

Corrigendum: LCN2 Is a Potential Biomarker for Radioresistance and Recurrence in Nasopharyngeal Carcinoma
por: Zhang, Meng-Xia, et al.
Publicado: (2021)

NOX activation in reactive astrocytes regulates astrocytic LCN2 expression and neurodegeneration
por: Liu, Ruijia, et al.
Publicado: (2022)

Tonicity inversely modulates lipocalin-2 (Lcn2/24p3/NGAL) receptor (SLC22A17) and Lcn2 expression via Wnt/β-catenin signaling in renal inner medullary collecting duct cells: implications for cell fate and bacterial infection
por: Betten, R., et al.
Publicado: (2018)

Update on the human and mouse lipocalin (LCN) gene family, including evidence the mouse Mup cluster is result of an “evolutionary bloom”
por: Charkoftaki, Georgia, et al.
Publicado: (2019)

The Lcn2-engineered HEK-293 cells show senescence under stressful condition
por: Bahmani, Bahareh, et al.
Publicado: (2015)

Identification of CCL20 and LCN2 as Efficient Serological Tools for Detection of Hepatocellular Carcinoma
por: Du, Lin, et al.
Publicado: (2022)

Lcn2 mediates adipocyte-muscle-tumor communication and hypothermia in pancreatic cancer cachexia
por: Lemecha, Mengistu, et al.
Publicado: (2022)

Biochemical and Structural Characterization of the Interaction between the Siderocalin NGAL/LCN2 (Neutrophil Gelatinase-associated Lipocalin/Lipocalin 2) and the N-terminal Domain of Its Endocytic Receptor SLC22A17
por: Cabedo Martinez, Ana-Isabel, et al.
Publicado: (2016)

Network based analyses of gene expression profile of LCN2 overexpression in esophageal squamous cell carcinoma
por: Wu, Bingli, et al.
Publicado: (2014)

Peritumoral SPARC expression and patient outcome with resectable intrahepatic cholangiocarcinoma
por: Cheng, Chi-Tung, et al.
Publicado: (2015)

Globo H Is a Promising Theranostic Marker for Intrahepatic Cholangiocarcinoma
por: Hung, Tsai‐Hsien, et al.
Publicado: (2021)

An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment
por: Xu, Wen-Xiu, et al.
Publicado: (2020)

LCN2 is a new diagnostic biomarker and potential therapeutic target in idiopathic short stature
por: Liu, Xijuan, et al.
Publicado: (2022)

48th IEEE Conference on Local Computer Networks (LCN 2023)
por: Bulut, Eyuphan, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_luknbkng52tvvf8f4r5h9mb5hk